A phase II study of capecitabine, irinotecan, and bevacizumab in patients with previously untreated metastatic colorectal cancer (Q57896517)
Jump to navigation
Jump to search
scientific article published on 15 February 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase II study of capecitabine, irinotecan, and bevacizumab in patients with previously untreated metastatic colorectal cancer |
scientific article published on 15 February 2012 |
Statements
A phase II study of capecitabine, irinotecan, and bevacizumab in patients with previously untreated metastatic colorectal cancer (English)
Stephen Welch
Jennifer Knox
Ronald Feld
Helen MacKay
Jennifer Petronis
Lisa Wang
Eric Chen
Daniel J Renouf
15 February 2012
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference